Education
About Us
Working with TipRanks
Follow Us
RaQualia Pharma Inc. (JP:4579)
:4579
RESEARCH TOOLSreports
Total Valuation
RaQualia Pharma Inc. has a market cap or net worth of ¥13.06B. The enterprise value is ¥22.38B.
Market Cap¥13.06B
Enterprise Value¥22.38B
Share Statistics
RaQualia Pharma Inc. has 24,457,172 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,457,172
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
RaQualia Pharma Inc.’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -3.26%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-3.26%
Return on Capital Employed (ROCE)-0.03
Revenue Per Employee48.56M
Profits Per Employee-7.73M
Employee Count64
Asset Turnover0.32
Inventory Turnover3.73
Valuation Ratios
The current PE Ratio of RaQualia Pharma Inc. is -16.79. RaQualia Pharma Inc.’s PEG ratio is -8.20.
PE Ratio-16.79
PS Ratio0.00
PB Ratio4.70
Price to Fair Value1.49
Price to FCF17.84
Price to Operating Cash Flow17.45
PEG Ratio-8.20
Income Statement
In the last 12 months, RaQualia Pharma Inc. had revenue of 3.11B and earned -495.03M in profits. Earnings per share was -22.87.
Revenue3.11B
Gross Profit2.48B
Operating Income-213.38M
Pretax Income-357.73M
Net Income-495.03M
EBITDA188.27M
Earnings Per Share (EPS)-22.87
Cash Flow
In the last 12 months, operating cash flow was 289.54M and capital expenditures -94.64M, giving a free cash flow of 194.90M billion.
Operating Cash Flow289.54M
Free Cash Flow194.90M
Free Cash Flow per Share7.97
Dividends & Yields
RaQualia Pharma Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.67
52-Week Price Change-9.56%
50-Day Moving Average546.12
200-Day Moving Average456.37
Relative Strength Index (RSI)45.35
Average Volume (3m)363.20K
Important Dates
RaQualia Pharma Inc. upcoming earnings date is Aug 14, 2025, TBA (Confirmed).
Last Earnings DateMay 15, 2025
Next Earnings DateAug 14, 2025
Ex-Dividend Date―
Financial Position
RaQualia Pharma Inc. as a current ratio of 3.82, with Debt / Equity ratio of 4.04%
Current Ratio3.82
Quick Ratio3.68
Debt to Market Cap0.38
Net Debt to EBITDA1.65
Interest Coverage Ratio-5.01
Taxes
In the past 12 months, RaQualia Pharma Inc. has paid 137.30M in taxes.
Income Tax137.30M
Effective Tax Rate-0.38
Enterprise Valuation
RaQualia Pharma Inc. EV to EBITDA ratio is 45.80, with an EV/FCF ratio of 102.36.
EV to Sales2.77
EV to EBITDA45.80
EV to Free Cash Flow102.36
EV to Operating Cash Flow47.65
Balance Sheet
RaQualia Pharma Inc. has ¥2.76B in cash and marketable securities with ¥3.34B in debt, giving a net cash position of ¥580.06M billion.
Cash & Marketable Securities¥2.76B
Total Debt¥3.34B
Net Cash¥580.06M
Net Cash Per Share¥23.72
Tangible Book Value Per Share¥77.07
Margins
Gross margin is 92.06%, with operating margin of -6.87%, and net profit margin of -15.93%.
Gross Margin92.06%
Operating Margin-6.87%
Pretax Margin-11.51%
Net Profit Margin-15.93%
EBITDA Margin6.06%
EBIT Margin-6.87%
Analyst Forecast
The average price target for RaQualia Pharma Inc. is ¥666.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target¥666.00
Price Target Upside24.72% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast57.13%
EPS Growth Forecast-66.39%